Research programme: nitric oxide donors - Rocket Pharmaceuticals
Alternative Names: Nitric oxide-releasing compounds - Rocket PharmaceuticalsLatest Information Update: 09 Jan 2018
At a glance
- Originator Inotek Pharmaceuticals
- Class
- Mechanism of Action Nitric oxide donors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Diabetic foot ulcer; Female sexual dysfunction
Most Recent Events
- 04 Jan 2018 Rocket Pharmaceuticals merged with Inotek Pharmaceuticals and the combined company was named Rocket Pharmaceuticals
- 08 Aug 2007 Discontinued - Preclinical for Diabetic foot ulcer in USA (Topical)
- 08 Aug 2007 Discontinued - Preclinical for Female sexual dysfunction in USA (unspecified route)